ARDS

ARIDIS PHARMACEUTICAL INC by Aridis Pharmaceuticals Inc. (ARDS)

About ARIDIS PHARMACEUTICAL INC by Aridis Pharmaceuticals Inc. (ARDS)

Aridis Pharmaceuticals, Inc. engages in the discovery and development of targeted immunotherapy using human monoclonal antibodies, or mAbs, to treat infections. The company was founded by Eric J. Patzer and Vu L. Truong on April 24, 2003 and is headquartered in Los Gatos, CA.

Details

Daily high
$0.00
Daily low
$0.00
Price at open
$0.00
52 Week High
$0.05
52 Week Low
$0.00
Market cap
8,900
Dividend yield
0.00%
Volume
15,189
Avg. volume
8,235
P/E ratio
--

ARIDIS PHARMACEUTICAL INC by Aridis Pharmaceuticals Inc. News

Details

Daily high
$0.00
Daily low
$0.00
Price at open
$0.00
52 Week High
$0.05
52 Week Low
$0.00
Market cap
8,900
Dividend yield
0.00%
Volume
15,189
Avg. volume
8,235
P/E ratio
--